Attached files
| file | filename |
|---|---|
| 8-K - Jiangbo Pharmaceuticals, Inc. | v217403_8k.htm |
Exhibit 16.1
April 4, 2011
Securities and Exchange Commission
405 Fifth Street, NW
Washington, D.C. 20549
Gentlemen:
We have read Item 4.01, and are in agreement with, the statements as they related to our firm being made by Jiangbo Pharmaceutical, Inc. in Item 4.01 of its Form 8-K filed with the SEC on April 4, 2011, captioned “Changes in Registrant’s Certifying Accountant.” We have no basis to agree or disagree with the other statements contained therein.
/s/ Frazer Frost, LLP
135 South State College Boulevard, Suite 300 | Brea, California 92821 | 714.990.1040 | frazerfrost.com
Los Angeles and Visalia, CA
FRAZER FROST, LLP is an independent firm associated with Moore Stephens International Limited.